MTOR and glioma: Metformin may indirectly or directly affect the phosphorylation and nuclear translocation of STAT3 through the AMPK-mTOR pathway, thereby reducing its transcriptional activity and inhibiting the malignant phenotype associated with glioma stem cells (84, 87–89).